The First-Line Insomnia Treatment Is Not on the Supplement Shelf

The recommendation is not ours. NCCIH reports that clinical practice guidelines issued by the American Academy of Sleep Medicine in 2021 recommend multicomponent cognitive behavioural therapy for insomnia for adults with chronic insomnia disorder.

Read that again. The first line treatment is a set of behaviours. Not a pill, and not a plant. It is a fixed wake time, a bed used only for sleeping, and a written record of what the nights are doing.

That is unglamorous, and it is also the reason it works. You can start the first three steps tonight for nothing.

Take magnesium, the aisle's current favourite. NCCIH's review is blunt: there is very little research on magnesium supplements for insomnia and other sleep disorders, so there is not enough rigorous evidence to say whether they work.

The picture is similar across most of the shelf. Some products have a little evidence, some have almost none, and none of them is the recommended starting point.

That is not an argument for taking nothing. It is an argument for taking the free part first, so you can tell what any bottle is actually doing.

Once the free part is running, a supplement becomes a fair test rather than a guess. The rules for that test are the same rules the NIH Office of Dietary Supplements gives for any product. The FDA does not check whether a supplement works before it goes on sale. Outside seals from groups such as NSF, USP and ConsumerLab confirm a product was made well and holds what the label says, but a seal does not promise the product is safe or that it works.

So a seal is a quality signal, not a results signal. Add one product, at one amount, at one hour, after the fortnight. Change nothing else while you do it.

Relaxation approaches are worth pairing with it. NCCIH's review of stress, anxiety and sleep problems covers those alongside the supplements, and they cost nothing to try.